Aquestive Therapeutics, Inc. (AQST) Deep Dive Video
Summary
Aquestive is a high-risk, high-upside biotech inflection story: a de-risked balance sheet and differentiated needle-free epinephrine film could unlock major value if Anaphylm clears its final FDA usability hurdles.